CDC advisors broaden RSV vaccine recommendations to at-risk adults in their 50s on April 16, 2025 50–59 Adult Age Arexvy broaden Centers for Disease Control and Prevention (U.S.) Chronic Condition Recommendation Respiratory syncytial virus Severe (severity modifier) Vaccines +